newsfilter
← Latest News
Business Wire·

Prothena to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that it will report